Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares US Aerospace & Defense ETF (ITA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

iShares US Aerospace & Defense ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares US Aerospace & Defense ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? iShares US Aerospace & Defense ETF trades at $204.45 (market cap $11.96B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: iShares US Aerospace & Defense ETF is far larger — about 6.6× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, iShares US Aerospace & Defense ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares US Aerospace & Defense ETF for 24 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

ITAVIR
Market Cap
$11.96B$1.80B
Volume
750,5771,782,836
Sector
Sector/ThematicHealth
52-Week High
$253.22$11.78
52-Week Low
$198.23$5.12
Typical Hold Time
24 Days0 Days
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares US Aerospace & Defense ETF

ITA trades at $204.00, down 0.99% with bearish technical signals from moving averages. The ETF shows neutral oscillators but faces selling pressure with RSI at oversold levels. Recent corporate actions include a 1:3 stock split scheduled for November 2026 and a $0.25 dividend payment in September 2026. Defense sector momentum remains strong with multiple contract wins and geopolitical tensions driving demand.

The defense sector outlook appears favorable with increased government spending and geopolitical tensions, though ITA faces technical headwinds. Key risks include defense budget volatility and geopolitical resolution. Analyst sentiment remains mixed with the ETF positioned to benefit from ongoing military modernization programs and replenishment of defense inventories.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ITA

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About iShares US Aerospace & Defense ETF

iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.

Read more on ITA →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →